arrow
A

Allison A. King

Washington University in St. Louis
H指数:46
被引数:8,519

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Radiation-Free Haploidentical Transplantation With PTCy and Extended Abatacept in Pediatric Nonmalignant Disorders

无放射的同种半相合移植联合PTCy和延长使用阿巴西特治疗儿童非恶性疾病

2026-10-020
OAAI
Motixafortide (CXCR4 Inhibition) Alone and in Combination with Natalizumab (VLA-4 Inhibition) As a Novel Regimen to Mobilize Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease: A First-in-Human, Proof-of-Principle Safety and Feasibility Study

Motixafortide(CXCR4抑制)单独及联合Natalizumab(VLA-4抑制)作为动员造血干细胞用于镰状细胞病基因治疗的新型方案:一项首次人体、原理验证的安全性及可行性研究

BLOOD
IF23.1
2024-11-050
PRE
High Concordance between Investigator-Verified Diagnosis and Manual Data Abstraction for Sickle Cell Diagnosis Type: An ASH Research Collaborative Data Hub Validation Study

研究者确认诊断与手动数据提取在镰状细胞病诊断类型方面的高一致性:一项ASH研究协作数据中心的验证研究

BLOOD
IF23.1
2024-11-050
PRE
Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department

个性化疼痛计划对急诊科治疗镰状细胞病血管闭塞发作的影响

2024-10-110
OAAI
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study
2024-07-021
PRE